Ehab A. ElGabry

Roche (United States) — United States

Medicine · Health Sciences

19h-index2.4kcitations49works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(9), Bladder and Urothelial Cancer Treatments(7), Cancer Genomics and Diagnostics(7), CAR-T cell therapy research(5), Prostate Cancer Diagnosis and Treatment(4)

Publications47 total

Correction: Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring
Diagnostic Pathology·2025Open Access
Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring
Diagnostic Pathology·2023· 48 citedOpen Access
Tumor Area Positivity (TAP) score of programmed death-ligand 1 (PD-L1): a novel visual estimation method for combined tumor cell and immune cell scoring
Research Square (Research Square)·2022· 3 citedOpen Access
Proceedings From the ASCO/College of American Pathologists Immune Checkpoint Inhibitor Predictive Biomarker Summit
JCO Precision Oncology·2022· 11 citedOpen Access
Pathology Education Powered by Virtual and Digital Transformation: Now and the Future
Archives of Pathology & Laboratory Medicine·2022· 59 citedOpen Access
Rules of engagement: Promoting academic-industry partnership in the era of digital pathology and artificial intelligence
Academic Pathology·2022· 41 citedOpen Access
Optimizing Run Control Performance in Tissue-Based Biomarker Testing: Experience of an Industry-Based CAP/CLIA Laboratory
American Journal of Clinical Pathology·2021Open Access
1125P Analytical assessment of a diagnostic immunohistochemical assay for the detection of folate receptor-ɑ in epithelial ovarian cancers
Annals of Oncology·2021· 1 cited
Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade
Journal for ImmunoTherapy of Cancer·2021· 144 citedOpen Access
Quantitative Image Analysis for Tissue Biomarker Use: A White Paper From the Digital Pathology Association
Applied immunohistochemistry & molecular morphology·2021· 80 citedOpen Access
Programmed Cell Death Ligand 1 Pathologist Training in the Time of COVID-19: Our Experience using a Digital Solution
Journal of Pathology Informatics·2021Open Access
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
npj Breast Cancer·2020· 18 citedOpen Access
Abstract PD5-02: Effective and globally reproducible digital pathologist training program on PD-L1 immunohistochemistry scoring on immune cells as a predictive biomarker for cancer immunotherapy in triple negative breast cancer
Cancer Research·2020· 5 cited
Delta-like Protein 3 Prevalence in Small Cell Lung Cancer and DLL3 (SP347) Assay Characteristics
Archives of Pathology & Laboratory Medicine·2019· 28 citedOpen Access
List of Contributors
Elsevier eBooks·2019
Immunohistochemistry
Elsevier eBooks·2019· 1 cited
Robustness of DLL3 (SP347) immunohistochemistry assay for detection of DLL3 protein in small cell lung cancer
Annals of Oncology·2018· 1 citedOpen Access
P2.09-09 Precision and Repeatability of VENTANA DLL3 (SP347) Assay Immunohistochemistry Assay in Fine Needle Aspirations of Small Cell Lung Cancer
Journal of Thoracic Oncology·2018
Long-term Clinical Outcomes and Biomarker Analyses of Atezolizumab Therapy for Patients With Metastatic Triple-Negative Breast Cancer
JAMA Oncology·2018· 774 citedOpen Access
An anti–glypican 3/CD3 bispecific T cell–redirecting antibody for treatment of solid tumors
Science Translational Medicine·2017· 196 cited
page 1 of 3Next →

Frequent Co-authors

Leonard G. Gomella(8), Stephen E. Strup(6), Demetrius H. Bagley(5), Liron Pantanowitz(5), Marilyn M. Bui(4), Anil V. Parwani(4), Brittany Admire(4), Janine Feng(4), David L. Rimm(3), Chunyan Liu(3), Ying Kong(3), Richard K. Valicenti(3), Chandru P. Sundaram(3), Burton F. Holmes(3), R. Marati(3), D. Tyree(3), D. Dalvi(3), Shahla Masood(3), Chuhua Zhang(3), Walid E. Khalbuss(3)